Biotech cluster operator and contract research services provider in Lyon
Lyonbiopole operates as a biocluster federation and active contract research organization across France and the UAE, with over 250 member organizations ranging from pharma leaders to academic centers. The hiring velocity is accelerating with 57 roles posted in the last 30 days—notably manufacturing-heavy (31 open roles) alongside engineering and research—signaling expansion into new in vivo and gene-therapy infrastructure. Stack adoption of SAP and active projects around facility commissioning and automation point to operational scaling, though regulatory compliance and raw-material sourcing remain persistent constraints.
Lyonbiopole is a nonprofit biocluster and contract research organization headquartered in Lyon, France, founded in 2005. It operates across the Auvergne-Rhône-Alpes region with an international presence in the UAE. The organization functions as both a community hub for 250+ members—including pharmaceutical companies, research centers, and university hospitals—and as a direct service provider in contract manufacturing and bioanalytical services (HPLC, LC-MS, qPCR, DICOM/PACS infrastructure). Active projects include facility expansion for infectious disease and gene-therapy research at higher biosafety levels, biobank development, and 3D biomaterial platform advancement. Operations are regulated under Class II medical device frameworks with ongoing focus on manufacturing automation and supply-chain resilience.
Core tools: SAP (now adopting), Salesforce, Veeva Vault, JMP, GraphPad Prism; lab instruments: HPLC, LC-MS, qPCR, SDS-PAGE, DICOM/PACS; dev: C++, Git, Subversion; infrastructure: GCP, Windows, Linux; Office suite and legacy Access/SharePoint for operations.
Primarily France (headquarters in Lyon, Rhône-Alpes region). Secondary hiring footprint in the United Arab Emirates. Total active headcount target spans 118 open roles across both geographies.
Other companies in the same industry, closest in size